{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Nanoemulsion", "query": { "intervention": "Nanoemulsion" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 11, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Nanoemulsion&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-02T17:42:07.567Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05397119", "title": "A Safety and Immunogenicity of Intranasal Nanoemulsion Adjuvanted Recombinant Pandemic Flu Vaccine in Healthy Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Influenza, Pandemic" ], "interventions": [ { "name": "BW-1014: 25 µg rH5 in 20% NE - pipette - IN", "type": "BIOLOGICAL" }, { "name": "BW-1014: 50 µg rH5 in 20% NE - pipette - IN", "type": "BIOLOGICAL" }, { "name": "BW-1014: 100 µg rH5 in 20% NE - pipette - IN", "type": "BIOLOGICAL" }, { "name": "rH5 (100 µg) control - pipette - IN", "type": "BIOLOGICAL" }, { "name": "Saline (Placebo) - pipette - IN", "type": "BIOLOGICAL" }, { "name": "H5N1 IIV - IM", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "BlueWillow Biologics", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 40, "start_date": "2022-07-07", "completion_date": "2023-10-12", "has_results": true, "last_update_posted_date": "2026-07-30", "last_synced_at": "2026-09-02T17:42:07.567Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT05397119" }, { "nct_id": "NCT04249076", "title": "Clobetasol Propionate Ophthalmic Nanoemulsion 0.05% for the Treatment of Inflammation and Pain Associated With Cataract Surgery (CLOSE-2)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Cataract" ], "interventions": [ { "name": "Clobetasol Propionate", "type": "DRUG" }, { "name": "Vehicle", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Salvat", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 215, "start_date": "2020-06-04", "completion_date": "2021-04-14", "has_results": true, "last_update_posted_date": "2022-12-22", "last_synced_at": "2026-09-02T17:42:07.567Z", "location_count": 18, "location_summary": "Sun City, Arizona • Hemet, California • Inglewood, California + 15 more", "locations": [ { "city": "Sun City", "state": "Arizona" }, { "city": "Hemet", "state": "California" }, { "city": "Inglewood", "state": "California" }, { "city": "Newport Beach", "state": "California" }, { "city": "Petaluma", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04249076" }, { "nct_id": "NCT03785340", "title": "Study of Brimonidine Tartrate Nanoemulsion Eye Drop Solution in the Treatment of Dry Eye Disease (DED)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Dry Eye" ], "interventions": [ { "name": "Brimonidine Tartrate", "type": "DRUG" }, { "name": "Placebos", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Ocugen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 252, "start_date": "2018-12-03", "completion_date": "2019-02-25", "has_results": true, "last_update_posted_date": "2022-07-18", "last_synced_at": "2026-09-02T17:42:07.567Z", "location_count": 16, "location_summary": "Newport Beach, California • Rancho Cordova, California • Pompano Beach, Florida + 11 more", "locations": [ { "city": "Newport Beach", "state": "California" }, { "city": "Rancho Cordova", "state": "California" }, { "city": "Pompano Beach", "state": "Florida" }, { "city": "Hoffman Estates", "state": "Illinois" }, { "city": "Mission", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03785340" }, { "nct_id": "NCT06546709", "title": "DMID 23-0015; Lassa Fever CVD 1000", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Lassa Fever" ], "interventions": [ { "name": "LASSARAB+ aPHAD-SEat 700rU", "type": "BIOLOGICAL" }, { "name": "HDCV Comparator", "type": "BIOLOGICAL" }, { "name": "Normal Saline Placebo", "type": "OTHER" }, { "name": "LASSARAB+ aPHAD-SEat 1400rU", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "Wilbur Chen, MD, MS", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 55, "start_date": "2025-01-13", "completion_date": "2026-05", "has_results": false, "last_update_posted_date": "2026-06-01", "last_synced_at": "2026-09-02T17:42:07.567Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT06546709" }, { "nct_id": "NCT04246801", "title": "Clobetasol Propionate Ophthalmic Nanoemulsion 0.05% for the Treatment of Inflammation and Pain Associated With Cataract Surgery (CLOSE-1)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Cataract" ], "interventions": [ { "name": "Clobetasol propionate", "type": "DRUG" }, { "name": "Vehicle", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Salvat", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 250, "start_date": "2020-06-10", "completion_date": "2021-05-19", "has_results": true, "last_update_posted_date": "2022-12-22", "last_synced_at": "2026-09-02T17:42:07.567Z", "location_count": 22, "location_summary": "Chandler, Arizona • Beverly Hills, California • Glendora, California + 19 more", "locations": [ { "city": "Chandler", "state": "Arizona" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Glendora", "state": "California" }, { "city": "Murrieta", "state": "California" }, { "city": "Pasadena", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04246801" }, { "nct_id": "NCT03591874", "title": "Study of Brimonidine Tartrate Nanoemulsion Eye Drops in Patients With Ocular Graft-vs-Host Disease", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Graft Versus Host Disease", "Ocular Surface Disease", "oGVHD", "Ocular Graft vs Host Disease", "Brimonidine Tartrate", "Lubricant Eye Drops", "Ophthalmic Solutions", "Graft vs Host Disease" ], "interventions": [ { "name": "Brimonidine Tartrate", "type": "DRUG" }, { "name": "Placebos", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Ocugen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 59, "start_date": "2018-12-23", "completion_date": "2020-04-30", "has_results": true, "last_update_posted_date": "2022-07-06", "last_synced_at": "2026-09-02T17:42:07.567Z", "location_count": 13, "location_summary": "Phoenix, Arizona • Palo Alto, California • Atlanta, Georgia + 10 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Palo Alto", "state": "California" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Prairie Village", "state": "Kansas" }, { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT03591874" }, { "nct_id": "NCT01975363", "title": "Pilot Study of Curcumin for Women With Obesity and High Risk for Breast Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Atypical Ductal Breast Hyperplasia", "BRCA1 Gene Mutation", "BRCA2 Gene Mutation", "Ductal Breast Carcinoma in Situ", "Lobular Breast Carcinoma in Situ" ], "interventions": [ { "name": "curcumin", "type": "DIETARY_SUPPLEMENT" }, { "name": "Biomarker analysis", "type": "OTHER" }, { "name": "Assessment of Dietary Intake", "type": "OTHER" }, { "name": "Daily Log", "type": "OTHER" } ], "intervention_types": [ "DIETARY_SUPPLEMENT", "OTHER" ], "sponsor": "Ohio State University Comprehensive Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "19 Years", "maximum_age": null, "sex": "FEMALE", "summary": "19 Years and older · Female only" }, "enrollment_count": 29, "start_date": "2013-06", "completion_date": "2016-09-19", "has_results": false, "last_update_posted_date": "2019-08-30", "last_synced_at": "2026-09-02T17:42:07.567Z", "location_count": 1, "location_summary": "Columbus, Ohio", "locations": [ { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT01975363" }, { "nct_id": "NCT03865992", "title": "Curcumin in Reducing Joint Pain in Breast Cancer Survivors With Aromatase Inhibitor-Induced Joint Disease", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Breast Cancer", "Joint Pain" ], "interventions": [ { "name": "Curcumin", "type": "DIETARY_SUPPLEMENT" }, { "name": "Placebo", "type": "OTHER" }, { "name": "Nanoemulsion", "type": "OTHER" }, { "name": "Quality-of-Life Assessment", "type": "OTHER" }, { "name": "Questionnaire", "type": "BEHAVIORAL" } ], "intervention_types": [ "DIETARY_SUPPLEMENT", "OTHER", "BEHAVIORAL" ], "sponsor": "City of Hope Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "FEMALE", "summary": "Female only" }, "enrollment_count": 42, "start_date": "2019-03-04", "completion_date": "2026-09-08", "has_results": false, "last_update_posted_date": "2025-11-10", "last_synced_at": "2026-09-02T17:42:07.567Z", "location_count": 4, "location_summary": "Duarte, California • Rancho Cucamonga, California • South Pasadena, California + 1 more", "locations": [ { "city": "Duarte", "state": "California" }, { "city": "Rancho Cucamonga", "state": "California" }, { "city": "South Pasadena", "state": "California" }, { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT03865992" }, { "nct_id": "NCT01695187", "title": "NB-001 Treatment of Recurrent Herpes Labialis", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Herpes Labialis" ], "interventions": [ { "name": "NB-001 (0.3%)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "NanoBio Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 362, "start_date": "2012-10", "completion_date": "2013-07", "has_results": false, "last_update_posted_date": "2013-06-14", "last_synced_at": "2026-09-02T17:42:07.567Z", "location_count": 12, "location_summary": "Chandler, Arizona • Tucson, Arizona • Chicago, Illinois + 9 more", "locations": [ { "city": "Chandler", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Lexington", "state": "Kentucky" }, { "city": "Edina", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT01695187" }, { "nct_id": "NCT03492541", "title": "Study of Efficacy and Tolerability of SYSTANE Complete in Patients With Dry Eye Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Dry Eye Disease" ], "interventions": [ { "name": "Propylene glycol-based eye drops", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Alcon Research", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 134, "start_date": "2018-07-18", "completion_date": "2019-05-14", "has_results": false, "last_update_posted_date": "2019-06-12", "last_synced_at": "2026-09-02T17:42:07.567Z", "location_count": 3, "location_summary": "Kansas City, Missouri • Norfolk, Virginia", "locations": [ { "city": "Kansas City", "state": "Missouri" }, { "city": "Kansas City", "state": "Missouri" }, { "city": "Norfolk", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT03492541" } ] }